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Abstract
Maternal exposure to marijuana during the lactation period—either active or passive—has 
prompted concerns about transmission of cannabinoids to breastfed infants and possible 
subsequent adverse health consequences. Assessing these health risks requires a sensitive 
analytical approach that is able to quantitatively measure trace-level cannabinoids in breast milk. 
Here, we describe a saponification–solid phase extraction approach combined with ultra-high-
pressure liquid chromatography–tandem mass spectrometry for simultaneously quantifying Δ9-
tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabinol (CBN) in breast milk. We 
demonstrate for the first time that constraints on sensitivity can be overcome by utilizing alkaline 
saponification of the milk samples. After extensively optimizing the saponification procedure, the 
validated method exhibited limits of detections of 13, 4, and 66 pg/mL for THC, CBN, and CBD, 
respectively. Notably, the sensitivity achieved was significantly improved, for instance, the limits 
of detection for THC is at least 100-fold more sensitive compared to that previously reported in the 
literature. This is essential for monitoring cannabinoids in breast milk resulting from passive or 
nonrecent active maternal exposure. Furthermore, we simultaneously acquired multiple reaction 
monitoring transitions for 12C- and 13C-analyte isotopes. This combined analysis largely 
facilitated data acquisition by reducing the repetitive analysis rate for samples exceeding the linear 
limits of 12C-analytes. In addition to high sensitivity and broad quantitation range, this method 
delivers excellent accuracy (relative error within ±10%), precision (relative standard deviation 
<10%), and efficient analysis. In future studies, we expect this method to play a critical role in 
assessing infant exposure to cannabinoids through breastfeeding.
Graphical Abstract
This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article 
or any adaptations for non-commercial purposes.




The authors declare no competing financial interest.
HHS Public Access
Author manuscript
ACS Omega. Author manuscript; available in PMC 2017 September 25.
Published in final edited form as:














Marijuana has been increasingly used for medical and recreational activities both globally 
and domestically.1,2 Worldwide, there were 177 million people aged 15–64 years, who used 
marijuana at least once in 2012, as reported by the United Nations Office on Drugs and 
Crime.1 In the United States, an estimated proportion using marijuana in the past month 
among person ≥12 years old increased from 6.2% in 2002 to 7.5% in 2013.3 As of 
November, 2016, 26 states and the District of Columbia have legalized medical marijuana 
use, and 8 states and the District of Columbia have legalized marijuana for recreational use, 
although both recreational and medical marijuana use remain illegal by federal law in the 
United States.
Within this context, it is anticipated that the use of marijuana in lactating women is 
increasing as well.4 Because cannabinoids, marijuana-specific components, for instance, Δ9-
tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabinol (CBN) (Figure 1), are 
highly lipophilic, a certain fraction of absorbed amounts following maternal marijuana 
exposure will be secreted into breast milk,5,6 resulting in breastfed infants’ exposure to these 
compounds. This exposure has raised concerns about possible negative impacts on infants’ 
early growth and neurodevelopment, including attention problems and decreased cognitive 
function.4,5,7
Despite many previous efforts,5,8,9 infant health risks associated with cannabinoid exposure 
via breast milk remain largely undetermined, precluding evidence-based guidance for 
medical providers and lactating mothers. Filling this void of actionable public health 
information requires an efficient analytical approach with sufficient sensitivity to 
quantitatively measure trace-level cannabinoids in breast milk.
Analytical methods for measuring cannabinoids in breast milk are limited in the literature. 
Currently, there is only one analytical method available in the open literature in which the 
researchers proposed a liquid–liquid extraction (LLE) procedure to separate cannabinoids 
from milk matrix, exhibiting a limit of detection (LOD) of 1.5 ng/mL for THC.10 The simple 
LLE procedure may provide sufficient sensitivity to measure levels of cannabinoids in those 
who actively use marijuana for medical or recreational purposes, but may not be suitable for 
detecting the passive marijuana smoke exposure that lactating mothers may experience. 
Moreover, false-negative detection of cannabinoids in milk samples from passive or 
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nonrecent past users by the analytical methods with high LODs will underestimate actual 
infant exposures and associated health risks.
Here, we describe an alkaline saponification–solid phase extraction (SPE) approach to 
separate cannabinoids from milk matrix. We demonstrate that saponification of the sample is 
crucial to separate cannabinoids from milk fats and, thus, to obtain the high selectivity and 
sensitivity essential for quantifying trace-level cannabinoids in breast milk from passive or 
nonrecent active marijuana exposure. Subsequently, we achieve chromatographic separation 
using ultra-high-pressure liquid chromatography (UPLC) and detection by tandem mass 
spectrometry (MS/MS). Additionally, to enable measurement of cannabinoids in breast milk 
from both active and passive users, we monitor multiple reaction monitoring (MRM) 
transitions for two naturally occurring analyte isotopes, 13C and 12C, respectively. This 
combined analysis significantly reduces the burden of sample preparation and facilitates data 
acquisition. Finally, we demonstrate that this method yields excellent accuracy, precision, 
linearity, robustness, and most importantly, ultrasensitivity at the picogram level.
2. RESULTS AND DISCUSSION
2.1. LLE by a Variety of Solvents
Human milk is a complex mixture composed of thousands of constituents including proteins, 
lipids, minerals, and many other solids.11 An effective cleanup procedure, separating 
cannabinoids from milk matrix, is crucial to achieve desired selectivity and sensitivity, 
especially considering that cannabinoids are highly lipophilic. Early in the method 
development process, we investigated LLE methods for extracting cannabinoids from milk 
matrix, and examined the performance of a variety of organic solvents, including hexane, 
ethyl acetate, acetone, methanol, and acetonitrile (0.5 mL milk sample extracted with 1.5 mL 
organic solvent, vortex shaking for 10 min for three times at room temperature) (Figure 2). 
Despite high average preparation efficiencies achieved when using 1.5 mL acidified 
methanol (5% formic acid) as LLE solvent (Figure 2), none of the solvents, used either alone 
or combined, provided preparation efficiencies that are able to reach the picogram per 
milliliter sensitivity level required to evaluate passive cannabinoid exposure. For instance, 
the average MS spiking IS preparation efficiency (PE) for THC was less than 2.5% (Figure 
2). Low PE by direct LLE approaches most likely result from interactions between 
cannabinoids and various milk constituents (i.e., proteins and fats), and/or potentially heavy 
ion suppression by co-extracted interferences.
2.2. Effects of Precipitation Salt and Ion-Pairing Reagent on Sensitivity
Seeking an effective approach to reduce co-extracted interferences and to increase the 
recovery, we examined the effects of salt protein precipitation and an ion-pairing reagent on 
sensitivity by adding 250 mg ammonium sulfate and 25 mM dibutylammonium acetate (ion-
pairing reagent) separately into two sets of parallel samples. Subsequently, we performed 
LLE using 1.5 mL of acidified methanol (0.5 mL milk sample, vortex shaking 10 min for 
three times at room temperature). Unfortunately, these tests yielded no significant 
improvement in sensitivity (Figure 3).
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2.3. Potential Chelation of Cannabinoids to Mineral Ions
We further speculated that the low sensitivity might be a result of potential chelation of 
cannabinoid molecules to mineral ions (e.g., Ca2+ and Mg2+), as these ions are relatively 
abundant in human breast milk11 and may have a non-negligible influence on recovery. If 
this were the case, adding a chelating agent, ethylenediaminetetraacetic acid (EDTA), would 
improve sensitivity by “freeing” cannabinoids from metal ions by forming stronger chelates 
with the ions. We then performed LLE with freshly prepared methanol containing 10 mM 
EDTA-Na2, 50 mM ammonium formate, and 5% formic acid (0.5 mL milk sample, vortex 
shaking 10 min for three times at room temperature). Despite higher MS spiking IS 
preparation efficiencies observed for THC and CBD following this approach, preparation 
efficiencies (Figure 4) for all analytes following these tests were still too low to detect trace-
level cannabinoids resulting from passive/light marijuana exposure. We conclude that 
cannabinoid chelation to mineral ions is not a key factor influencing extraction recovery 
(ER) and sensitivity.
2.4. Evaluation of Protein Digestion on Sensitivity
Before the LLE procedure, we evaluated the effect of protein digestion on sensitivity using 
proteinase K (10 units/mL in the sample, incubated at 37 °C for 2 h). If cannabinoids bind 
with milk proteins, this procedure could potentially liberate cannabinoids from proteins, thus 
increasing ER and sensitivity. After preparing the samples using the LLE procedure (0.5 mL 
milk sample, 1.5 mL acidified methanol, vortex shaking 10 min for three times at room 
temperature), we observed even lower IS PE following the protein digestion procedure 
(Figure 5). The lower efficiency might be caused by several factors: (1) cannabinoids could 
degrade during the protein digestion procedure; (2) cannabinoids could bind to the 
proteinase; and/or (3) the digested products could interfere with MS ionization, resulting in 
ion suppression.
2.5. Minimization of the Influences of Lipids on Sensitivity
Given that breast milk contains a large amount of lipids, potentially up to 5% by weight,11 
and that cannabinoids are highly lipophilic, we sought to determine whether cannabinoid–
lipid binding could be the cause of low sensitivity. We also speculated that formation of 
esters between cannabinoids and fatty acids could exist in breast milk, resulting in low 
recovery. To test these hypotheses, we assessed alkaline saponification using methanolic 
NaOH (details regarding experimental parameters are described in Section 2.6). In contrast 
to previous tests (Figures 2–5), we observed remarkable improvement in IS PE following 
saponification (Figure 6). We believe two major mechanisms underlie the improvement in 
sensitivity and efficiency. First is the conversion of triacylglycerols into water-soluble 
materials. Triacylglycerols account for >95% of breast milk lipids,11 and their conversion 
during saponification would reduce any triacylglycerol–cannabinoid binding and also reduce 
any ion suppression attributable to triacylglycerols. This might be true for similar 
interferences, as well. The second mechanism is the liberation of cannabinoids from fatty 
acids during saponification. If formation of esters between cannabinoids and fatty acids 
exists, the separation of the two, by converting fatty acids into sodium salts, would 
essentially eliminate the fatty acids from extracts.
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2.6. Optimization of Alkaline Saponification
We optimized the saponification procedure by evaluating methanolic NaOH volume/
concentration and saponification duration, while maintaining the temperature at 70 °C 
(Figure 6). We found that adding 0.5 mL of 1.25 M methanolic NaOH into each milk sample 
and incubating the sample for 30 min at 70 °C provided the highest MS sensitivity. The 
optimum saponification solution consisted of an approximate sample/methanol ratio of 1.0 
and a NaOH concentration of 0.57 M.
2.7. Combined Analysis of Milk Samples with Low and High Concentrations
Because milk samples from recent active users may have concentrations of 12C-analyte 
isotope far beyond the dynamic linear ranges of our MS detector, highly concentrated 
samples normally need to be diluted and re-prepared. Inspired by the study reported by 
Kotandeniya et al.,12 in which they combined the analysis of urinary cotinine and 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) using naturally occurring 13C-
transitions and 12C-transitions, respectively, we simultaneously monitored the 13C-analyte 
isotopes and used them to quantify high-concentration samples exceeding the linear MS 
responses for 12C-analyte isotopes to reduce the repetitive analysis rate because MRM 
transitions for naturally occurring 13C-analytes are at low levels. Although there are a 
number of studies which reported that the natural abundance of the stable isotopes of carbon, 
that is, 13C/12C, was approximately constant in various plants and grasses,13 no data are 
available regarding the ratio of 13C/12C in marijuana plants. Thus, this approach was based 
on the assumption that the natural abundance of the stable isotopes of carbon, 13C and 12C, 
is approximately constant. We compared the concentrations quantified on the basis of 12C-
transitions with those acquired using 13C-transitions, and we observed excellent agreement 
between them (Table 2). Because this approach can be used to evaluate both passive and 
active marijuana exposure, it would significantly reduce the rate of repetitive sample 
preparation and facilitate sample analysis.
2.8. Performance Evaluation of the Proposed Method
We evaluated method performance and determined LODs and limits of quantitation (LOQs) 
by preparing and analyzing 20 sets of 7 pools (10, 20, 50, 100, 150, 300, and 500 pg/mL). 
We first determined the standard deviation (SD) of each pool’s concentration, and then we 
plotted the SD of each pool against the concentration, and finally obtained S0 given as the Y 
intercepts. LODs and LOQs, calculated as 3S0 and 10S0, respectively, are presented in Table 
3. Figure 7 depicts chromatograms of three samples with concentrations close to LODs. The 
sensitivity achieved in this method for THC is at least 100-fold higher than literature values 
(i.e., LOD of 1.5 ng/mL for THC).10 No analytical method is currently available for 
measuring CBD and CBN in breast milk. For data reporting, we will be consistently using 
LODs obtained on the basis of 12C-analyte isotopes, although we used 13C-analyte isotopes 
to quantify high concentrations. We believe the marked increase in sensitivity will play an 
essential role in quantifying trace-level cannabinoids in breast milk resulting from passive or 
nonrecent active maternal marijuana exposure in future studies.
We used three sets of samples at low, medium, and high concentrations to determine 
optimized extraction recoveries, matrix effects (MEs), and sample PE. Average extraction 
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recoveries ranged from 9.4 to 60%, sample PE was in the range of 3.1–61%, and the ion 
suppression due to the ME varied from −67 to 29% (Table 3). Basically, we noticed that the 
recovery and ME at low, medium, and high levels for THC, CBD, and CBN were of 
comparable magnitudes, for example, PE for THC is in the range from 7.5 to 8.3%. 
Compared to lower concentrations, these measures (matrix effect and recovery) at higher 
concentrations are less important because there are no detection issues at higher 
concentrations. Considering there are few data available in the literature to get reliable 
ranges of milk concentrations in general population, we used a high concentration of 250 
ng/mL as a representative level to obtain the average values of recovery, ME, and sample PE 
in this study, although a level of 500 ng/mL was applied as the upper calibration end. A high 
upper calibration level will be helpful to reduce the repetitive rates of sample preparation 
and analysis.
The biggest challenge we met when developing this analytical method was that cannabinoids 
are highly lipophilic, and they can bind to lipids in human milk very tightly. After reviewing 
the literature, we only identified one study using the LLE method to separate THC from 
milk matrix.10 We examined the LLE method, and found it could not effectively extract the 
analytes from milk matrix, although it still worked for samples from active users as they had 
high concentrations, for example, above 1.0 ng/mL. We examined kinds of tests as described 
in the article and found that alkaline saponification of the milk samples is the only effective 
way to obtain high sensitivity that is indispensable for quantifying the concentrations of 
cannabinoids in milk samples from those persons exposed to second-hand marijuana smoke. 
Although the recovery and efficiency are low, this is the best method that can be achieved 
currently. We are continuously investigating whether there will be alternative approaches 
available in future, so as to improve the recovery, efficiency, and ME.
Finally, we evaluated the accuracy and precision of the proposed method by conducting 
replicate analyses of QC samples over 12 consecutive weeks. The validation results show 
excellent interday and intraday accuracy (within ±10%) and imprecision (<10%) (Table 3).
3. EXPERIMENTAL METHODS
3.1. Chemicals and Materials
We purchased high-purity methanol (≥99.9%), 2-propanol (≥99.9%), formic acid (≥99.5%), 
and ammonium formate (≥99%) from Fisher Scientific (Fair Lawn, NJ). We purchased 
liquid chromatography–mass spectrometry (LC–MS) grade water (J.T. Baker, ≥99.9%) and 
acetonitrile (Burdick & Jackson, ≥99.9%) from VWR (Radnor, PA). We purchased 
ammonium sulfate, sodium hydroxide (NaOH), ethylenediaminetetraacetic acid disodium 
salt dehydrate (EDTA-Na2), and 0.5 M dibutylammonium acetate from Sigma-Aldrich 
Laboratories, Inc. (St. Louis, MO). We purchased native and isotopically labeled standards, 
including THC, THC-d3, CBD, CBD-d3, CBN, and CBN-d3 from Cerilliant (Round Rock, 
TX). We bought the SPE (C18, 100 mg) column and 96-well plate from Phenomenex 
(Torrance, CA). All chemicals were used without further purification.
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3.2. Standard Solution Preparation
Human breast milk purchased from BioreclamationIVT (New York) was screened and used 
as blank matrix for calibration and quality control (QC) samples. The CDC Human Subjects 
Review Board determined that the use of breast milk from anonymous individuals for 
method development was not human subject research.
We prepared working solutions for calibrators and QC samples from serial dilutions of 
primary stock solutions with 60% methanol in water and stored these solutions in Teflon-
capped amber glass vials at −24 °C. Calibrators (0.001–500 ng/mL) and QC samples (0.15, 
25, and 250 ng/mL) were created by spiking 50 μL of each working solution into 500 μL of 
milk pool. Concentrations for THC-d3, CBD-d3, and CBN-d3 in the internal standard (IS) 
spiking solution were 0.01, 0.03, and 0.01 ng/μL, respectively.
3.3. Sample Preparation
We prepared calibrators, QC samples, batch blanks, and unknown samples following the 
same procedures. First, milk samples stored at temperatures ≤−65 °C were thawed and 
gently vortex-mixed for 5 min at room temperature. A sample volume of 0.50 mL was 
transferred to each 2.0 mL microcentrifugation vial, followed by the addition of 50 μL of 
calibrator and QC working solutions to each sample. Working solutions were replaced with 
water for blanks and unknown samples. Then, 50 μL of IS solution and 0.50 mL of 1.25 M 
methanolic NaOH were added to each vial. After gentle mixing, the vials were incubated at 
70 °C for 15 min, mixed a second time, and then incubated for an additional 15 min at 
70 °C. After cooling and equilibrating at 4 °C for 1 h, samples were gently vortex-mixed and 
centrifuged for 30 min at −6 °C, and then approximately 0.90 mL of clear solution was 
transferred into a 96-deep well plate in order. After adding 0.4 mL of water into each well 
and gentle mixing, samples were loaded onto a 96-well SPE plate, preconditioned with 1.0 
mL of methanol and 1.0 mL of water. After soaking for 15 min, the mixtures were pushed 
through the SPE under approximately 1.0 psi positive pressure. Samples were subsequently 
washed with 1.0 mL of water and 1.0 mL of methanol and water (v/v: 60:40). After drying 
for 15 min with nitrogen (25 psi), 1.0 mL of methanol was added to each sample. Then, the 
eluent was collected in a second 96-well plate and dried using nitrogen on a TurboVap 
evaporator (Biotage, Charlotte, NC) at room temperature. The residuals were reconstituted 
in 50 μL of methanol and water (v/v: 50:50), and 10 μL of each sample was injected into the 
UPLC system.
3.4. Instrumentation and Operation
We used a Shimadzu UPLC system (Columbia, MD) with a Kinetex reversed-phase column 
(100 mm × 2.1 mm, particle size 2.6 μm, C18) (Phenomenex, Torrance, CA) to achieve 
chromatographic separation. The gradient program contained 5.0 mM of ammonium formate 
with 0.05% formic acid (solvent A), and 100% acetonitrile (solvent B). We maintained the 
column flow rate at 0.4 mL/min and the temperature at 40 °C throughout the analysis. To 
minimize MS contamination, we directed the LC flow during the first 2.75 min and the last 
1.5 min to a waste container, using the incorporated switching valve on MS, and only 
allowed the low occurring between 2.75 and 4.5 min to the MS. Detailed gradient elution 
programs are shown in Table 1.
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We performed MS/MS analysis using a Sciex triple quadrupole 6500 with a TurboIonSpray 
source (Foster City, CA). We used positive electrospray ionization (ESI+) mode to acquire 
MRM transition data for THC and CBD, and ESI−mode for CBN. Because the MS response 
of some 12C-analyte isotopes may exceed the dynamic linear response of our MS detector, 
we also monitored naturally occurring 13C-analyte isotopes. If the response of the 12C-
isotope exceeded the linear response of the MS, the 13C-isotope was used for quantification. 
Monitoring of 13C-isotopes allowed quantification of samples that would have required 
dilution and repeat preparation for quantification using the 12C-analyte isotopes. Two MRM 
transitions for each native analyte and one transition for the isotope labeled IS were 
simultaneously monitored. Optimum MS source parameters were as follows:
• Source temperature: 600 °C.
• Ionspray voltage (ESI+/ESI−): 5500/−4500 V.
• Ion source gas-1: 80 psi.
• Ion source gas-2: 90 psi.
• Curtain gas: 35 psi.
• Target scan time (ESI+/ESI−): 0.19/0.18 s.
Detailed MRM transitions and voltage settings are shown in Table 2.
3.5. Determination of ER, Overall Efficiency, and ME
We determined ER, ME, and sample PE using three sets of samples at low (0.15 ng/mL for 
THC and CBN; 0.30 ng/mL for CBD), medium (25 ng/mL), and high (250 ng/mL) 
concentrations, as described elsewhere.14 In the first set, seven blank samples were fortified 
with native and deuterated IS solutions at the beginning of the sample preparation. In the 
second set of seven blank samples, spiking solutions were added immediately before LC 
injection. The third set of seven samples were prepared by spiking native and IS solutions in 
methanol and water (v/v: 50:50). The ER, ME, and PE values were calculated as follows
where A, B, and C were average peak areas of set 1, set 2, and set 3, respectively (Table 3).
3.6. Software for Data Acquisition
We used Analyst software (version 1.6.2) to acquire the chromatogram and quantify the 
concentration. Calibration curves were constructed using peak area ratios of analytes to the 
corresponding ISs for each batch via linear least-squares regression with a 1/x weighting 
factor.
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Molecular structures of major cannabinoids.
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Performance of LLE by a variety of organic solvents. Abbreviations: ACN, acetonitrile; IPA, 
isopropanol; DCM, dichloromethane; FA, formic acid.
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Examination of effects of precipitation salt and ion-pairing reagent on sensitivity. 
Abbreviation: FA, formic acid.
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Examination of potential chelation of cannabinoids to mineral ions. Abbreviation: FA, 
formic acid.
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Protein digestion conducted at different pH levels, followed by LLE with 1.5 mL acidified 
methanol.
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Optimization of saponification conditions. (a) Change in the average PE (%) with the 
volume of methanol; (b) change in the average PE with saponification duration; and (c) 
change in the average PE with methanolic NaOH concentration.
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Representative chromatograms of milk samples with concentrations close to LODs.
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Table 1
UPLC Gradient Elution Program
time module event parameter
0.01 system controller start
1.20 pumps %B 40
2.50 pumps %B 75
3.00 pumps %B 75
4.50 pumps %B 96
5.50 pumps %B 96
5.51 pumps %B 40
7.50 system controller stop
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